Dr. JuliusArden

Associate

Düsseldorf + 49.211.5406.5500

Connect:

Share

Julius Arden advises national and international clients on labor and employment matters. He also counsels companies on the liability of managing directors and has experience in designing remuneration systems. In addition, Julius advises national and international companies in commercial matters.

Prior to joining Jones Day, Julius worked for a German company in the automotive sector for more than two years and as a trainee at an international law firm, where he advised German and international clients on M&A and corporate matters.

Julius's Ph.D. thesis focused on executive board member liability in legal infringement cases.

Experience

  • Stellex completes buyout of David Brown Santasalo GroupJones Day advised Stellex Capital Management LLC on its buyout of DB Santasalo S.à r.l from N4 Partners.
  • Rejuvenate acquires entire business operations of cell transplants manufacturer co.don AktiengesellschaftJones Day advised Rejuvenate GmbH, a subsidiary of ReLive Biotechnologies, in connection with the acquisition of the business operations of co.don Aktiengesellschaft ("CO.DON") (including all shares in its Dutch, UK and Swiss subsidiaries).
  • Aurelius acquires three European paper mills from Sappi Limited in complex pan-European carve-out transactionJones Day is advising Aurelius in the acquisition of three European paper mills from Sappi Limited.
  • ProSiebenSat.1 Media SE’s investment arm SevenVentures invests in GroverJones Day advised SevenVentures, the investment arm of ProSiebenSat.1 Media SE, in its investment in Grover, the leading consumer-tech subscription platform.
  • ArchiMed acquires Cube Biotech GmbHJones Day advised ArchiMed, a leading Trans-Atlantic private equity healthcare specialist, on its acquisition of Cube Biotech GmbH, a leading provider of expression, purification, and crystallization services and products for membrane proteins.
  • SevenVentures invests in GroverJones Day represented SevenVentures, the investment arm of ProSiebenSat.1 Group, in connection with its investment in Grover, Europe's market leader in consumer tech subscriptions.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Milliken & Company acquires Zebra-chemJones Day advised Milliken & Company in its acquisition of Zebra-chem GmbH, a global chemicals company known for its peroxide and blowing agent masterbatches.
  • Meridian Adhesives Group acquires adhesives division of John P. KummerJones Day represented Meridian Adhesives Group, a portfolio company of Arsenal Capital Partners, in the acquisition of the adhesives division of John P. Kummer GmbH, AG and Ltd (JPK).
  • Milliken & Company acquires Borchers from The Jordan CompanyJones Day advised Milliken & Company in its acquisition of Borchers Group Limited, a global specialty chemicals company known for its innovative high-performance coating additives and specialty catalyst solutions, from The Jordan Company, L.P.
  • Amadeus FiRe AG acquires COMCAVE Holding GmbH, Dortmund for €200 millionJones Day advised Amadeus FiRe AG, Frankfurt, on the €200 million acquisition of 100% of the shares in the retraining specialist COMCAVE Holding GmbH, Dortmund.
  • Pandox AB purchases two hotel properties in Hanover and The Hague (Netherlands)Jones Day advised Pandox AB on the €83 million purchase of two hotel properties and the respective hotel operations in Hanover and The Hague (Netherlands) from Grape Hospitality.
    • View All

    Additional Publications

    • 2022
      Backhaus/Tielmann, Der Aufsichtsrat, 2. Auflage, §§ 87, 87a, 120a, 162, München 2022
    • 2022
      Arden, EuGH verweist Streit um Nachzuschläge zurück nach Deutschland, DB 2022, 2158
    • 2022
      Baur/Arden, Fehlendes Feststellungsinteresse im Zustimmungsersetzungsverfahren im Zusammenhang mit Home-Office, DB 2022, 1399
    • 2021
      Arden, Unverhältnismäßigkeit einer Betriebsvereinbarung, DB 2021, 1342
    • 2021
      Baur/Arden, Coronavirus: Arbeitsvergütung in Zeiten einer Pandemie, DB1328360
    • 2020
      Arden, Zurückweisung der Geschäftsführerkündigung bei grenzüberschreitenden Gesellschaftsstrukturen, DB 2020, 223
    • 2018
      Arden, Haftung der Geschäftsleiter und Aufsichtsratsmitglieder bei unklarer Rechtslage, Tübingen 2018

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.